Company / Working Capital per Share
Tyra Biosciences, Inc. Working Capital per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$5.82
FY2024
5-year range
$4.60 / $21.80
FY2020-FY2024
Trend
+26.5%
vs FY2023
Sector context
#97 of 210
Health Care
What the data says
At $5.82, Tyra Biosciences, Inc.'s working capital per share ranks #97 of 210 in the Health Care sector. Working Capital per Share returned to growth in FY2024 after 2 years of decline, reaching $5.82.
Based on SEC 10-K filings.
5.82 in FY2024 with a 3-year CAGR of -35.6%.
Declined from $6.01 to $5.82 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -35.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#97 of 210 in Health CareTop 46% of 210This company $5.82 Sector average $146.86
▼
-96.0% below sector average
Key checks
Key Insights
- In FY2024, working capital per share increased 26.5% year-over-year.
- Ranks #97 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2021.
- Lowest working capital per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 6.83 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $5.82 | +26.5% |
| FY2023 | $4.60 | -23.5% |
| FY2022 | $6.01 | -72.4% |
| FY2021 | $21.80 | +150.5% |
| FY2020 | $8.70 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026